Antiretroviral Improvement Among Medicaid Enrollees

Not Applicable

Terminated

• Conditions: Human Immunodeficiency Virus

• Registration Number: NCT05477485
• Lead Sponsor: Virginia Commonwealth University

Brief Summary

This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.

Detailed Description

Virginia Commonwealth University and study collaborators are working together to learn about challenges that Virginia Medicaid members have in taking their prescribed medication. To do this, the researchers are implementing and evaluating a program called Antiretroviral Improvement among Medicaid enrolleeS (AIMS). This program is designed to support members to fill ART prescriptions.

The program involves supporting Medicaid members with HIV directly by talking to them about challenges with filling their ART prescriptions and linking them to resources that can help with those challenges. Some members will be offered access to warm health technology support.

The researchers think this support may increase how often ART prescriptions are filled and hope that the AIMS program can improve individuals' health and increase HIV viral suppression.

Study Timeline

• Study First Submitted: 2022-07-26
• Study First Submitted QC: 2022-07-26
• Study First Posted: 2022-07-28
• Study Start: 2023-04-27
• Primary Completion: 2024-05-31
• Study Completion: 2024-05-31
• Results First Submitted: 2025-04-23
• Status Verified: 2025-10
• Results First Submitted QC: 2025-10-07
• Last Update Submitted: 2025-10-07
• Results First Posted: 2025-10-21
• Last Update Posted: 2025-10-21

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 4

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Number and Percentage of Participants Virally Suppressed	3 months	HIV viral load data come from Virginia Department of Health (VDH) routine surveillance. Viral load data indicate whether or not an individual was virally suppressed, i.e., the level of HIV in a blood sample was less than the detectable limit.

Secondary Outcome Measures

Name	Time	Method
Number and Percentage of Participants Reinitiating Late Antiretroviral Therapy (ART) Prescription	3 months	Data source is prescription claim(s) for antiretroviral therapy (ART) prescription(s) made available through Virginia Medicaid. Participants will be considered as reinitiating if they have a filled ART prescription after study enrollment.
Antiretroviral Therapy (ART) Adherence	3 months	Data source is prescription claim(s) for antiretroviral therapy (ART) made available through Virginia Medicaid. Participants will be considered adherent if their ART prescription claim(s) cover \>90% of enrolled coverage days.

Trial Locations

Locations (1)

Virginia Commonwealth University; 🇺🇸 Richmond, Virginia, United States